These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16024934)

  • 1. A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.
    Jessen F; Traeber F; Freymann N; Maier W; Schild HH; Heun R; Block W
    Dement Geriatr Cogn Disord; 2005; 20(2-3):178-83. PubMed ID: 16024934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
    Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease].
    Block W; Träber F; Kuhl CK; Fric M; Keller E; Lamerichs R; Rink H; Möller HJ; Schild HH
    Rofo; 1995 Sep; 163(3):230-7. PubMed ID: 7548870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.
    Jessen F; Block W; Träber F; Keller E; Flacke S; Papassotiropoulos A; Lamerichs R; Heun R; Schild HH
    Neurology; 2000 Sep; 55(5):684-8. PubMed ID: 10980734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment monitoring and response prediction with proton MR spectroscopy in AD.
    Jessen F; Traeber F; Freymann K; Maier W; Schild HH; Block W
    Neurology; 2006 Aug; 67(3):528-30. PubMed ID: 16894124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior to posterior hippocampal MRS metabolite difference is mainly a partial volume effect.
    Starck G; Vkhoff-Baaz B; Ljungberg M; Malmgren K; Forssell-Aronsson E; Jönsson L; Ekholm S
    Acta Radiol; 2010 Apr; 51(3):351-9. PubMed ID: 20201639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of NAA with aging outside the seizure focus in mesial temporal lobe epilepsy--a proton-MRS study at 3 Tesla.
    Riederer F; Bittsanský M; Lehner-Baumgartner E; Baumgartner C; Mlynárik V; Gruber S; Moser E; Kaya M; Serles W
    Brain Res; 2007 Nov; 1179():131-9. PubMed ID: 17936253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy.
    Li LM; Cendes F; Antel SB; Andermann F; Serles W; Dubeau F; Olivier A; Arnold DL
    Ann Neurol; 2000 Feb; 47(2):195-200. PubMed ID: 10665490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe.
    Träber F; Block W; Freymann N; Gür O; Kucinski T; Hammen T; Ende G; Pilatus U; Hampel H; Schild HH; Heun R; Jessen F
    Eur Radiol; 2006 May; 16(5):1096-103. PubMed ID: 16416279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.
    Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Kramer J; Jagust W; Miller B; Wolkowitz OM; Yaffe K; Weiner MW
    Neurology; 2002 Mar; 58(6):928-35. PubMed ID: 11914410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizure frequency and bilateral temporal abnormalities: a proton magnetic resonance spectroscopy of temporal lobe epilepsy.
    Someya Y; Obata T; Suhara T; Ota Y; Ikehira H; Tanada S; Hirakawa K; Okubo Y; Sasaki Y
    Seizure; 2000 Jun; 9(4):274-9. PubMed ID: 10880288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
    Lazeyras F; Charles HC; Tupler LA; Erickson R; Boyko OB; Krishnan KR
    Psychiatry Res; 1998 May; 82(2):95-106. PubMed ID: 9754452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.